Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Login
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press/Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
Optimal Selection of Targeted Therapies for Melanoma Patients: Role of the Mitogen-Activated Protein Kinase Pathway
Peter Lau
, Damien Kee
Research output
:
Chapter in Book/Conference paper
›
Chapter
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Optimal Selection of Targeted Therapies for Melanoma Patients: Role of the Mitogen-Activated Protein Kinase Pathway'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Nodular Melanoma
100%
Mitogen-Activated Protein Kinase
83%
Systemic Therapy
33%
Cutaneous Melanoma
16%
Metastatic Melanoma
16%
Combination Therapy
16%
Development
16%
Dabrafenib
16%
MEK Inhibitor
16%
Vemurafenib
16%
Therapeutic Procedure
16%
Comprehension
16%
Drive
16%
Survival
16%
Patient
16%
Targeted Therapy
16%
Drug Delivery System
16%